Sanofi · 3 hours ago
Senior Associate Scientist – CMC, Early-Stage Drug Product Development
Framingham, MA
Full-time
Onsite
Mid, Senior Level
$75K/yr - $108K/yrSanofi is an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. The Senior Associate Scientist will support the Research-to-Development transition of biologic drugs, focusing on developing patient-centric products and driving innovation in formulation science.
Health CareLife SciencePharmaceuticalTherapeutics
Responsibilities
Serve as an analytical contributor, where you will support the Research-to-Development transition of biologic drugs and play an important role in laying the foundation for successful commercial formulations
Contribute to developability assessments, preformulation studies, and formulation/DP process development activities
Support innovation projects focused on identifying the molecular determinants of high concentration solution behavior (viscosity, opalescence, phase separation, etc.) and other areas related to patient-centric product development
Qualification
Required
Strong scientific background in biochemistry, biophysics, and the pharmaceutical sciences
Experience with biochemical & biophysical assays including HPLC, CE-SDS, icIEF, CD, AUC, DSC, DLS/SLS, and mass spectrometry
Data fluency and a keen eye for data quality
Collaborative mindset with excellent communication skills
Education: Minimum BS or MS in a relevant field (or equivalent experience)
Languages: English
Benefits
High-quality healthcare
Prevention and wellness programs
At least 14 weeks’ gender-neutral parental leave
Company
Sanofi
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
Founded in 1973
10001+ employees
H1B Sponsorship
Sanofi has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (101)
2024 (68)
2023 (59)
2022 (78)
2021 (38)
2020 (38)
Funding
Current Stage
Public CompanyTotal Funding
$6.97BKey Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B
Leadership Team
Paul Hudson
Chief Executive Officer
Francois-Xavier Roger
Chief Financial Officer
Recent News
2026-01-23
2026-01-23
2026-01-23
Company data provided by crunchbase